
A new immunotherapy treatment for recurrent B-cell lymphoma was found to be safe in a trial of nearly 350 patients, according to a study published in The Lancet.

A recent Northwestern Medicine study has revealed previously unknown details about calcium signaling that can contribute to inflammation.

Starting cholesterol-lowering treatment earlier may increase the its benefits, reducing heart attack and stroke over time, according to a Northwestern Medicine study.

Feinberg principal investigators secured a record-breaking $643 million in research funding and awards during the 2019-2020 fiscal year.

Men with advanced prostate cancer who were treated based on the genetic makeup of their cancer survived significantly longer than those treated with standard treatments, according to a new study.

Northwestern Medicine investigators have discovered that a specialized protein associated with the microtubules of a cell helps facilitate and regulate early stages of HIV infection.

Inhibiting an epigenetic regulator called DOT1L could be a key to slowing treatment-resistant prostate cancer, according to a recent Northwestern Medicine study.

Biomarkers using mass cytometry can assess patient response to an emerging treatment for pediatric brain tumors, according to a recent multi-center study.

A mismatch between airway size and lung capacity, called dysanapsis, is a strong risk factor for chronic obstructive pulmonary disease, according to a new study.

Biological sex has a small but ubiquitous influence on gene expression in almost every type of human tissue, according to a new study.